MARSHALL & POPP, LLC
MARSHALL & POPP, LLC is named as the registrant in 40 lobbying reports we hold for 2026-Q2, for 40 clients. 0 reports of 40 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| 3M COMPANY | 2026-Q2: No amount stated | 1 |
| A PLACE FOR MOM, INC. | 2026-Q2: No amount stated | 1 |
| ABBOTT LABORATORIES | 2026-Q2: $60,000 in income | 1 |
| ABBVIE INC. | 2026-Q2: $60,000 in income | 1 |
| AICPA ASSOCIATION OF INTERNATIONAL CERTIFIED PROFESSIONAL ACCOUNTANTS | 2026-Q2: $50,000 in income | 1 |
| AIRPORTS COUNCIL INTERNATIONAL - NORTH AMERICA | 2026-Q2: $60,000 in income | 1 |
| ALTRIA CLIENT SERVICES | 2026-Q2: $60,000 in income | 1 |
| AMGEN USA INC. | 2026-Q2: $60,000 in income | 1 |
| ATLANTIC COAST CONFERENCE | 2026-Q2: No amount stated | 1 |
| BRIDGEBIO PHARMA | 2026-Q2: $60,000 in income | 1 |
| BRISTOL-MYERS SQUIBB COMPANY | 2026-Q2: $60,000 in income | 1 |
| BUTTERFLY NETWORK, INC. | 2026-Q2: No amount stated | 1 |
| CITIZENS FOR RESPONSIBLE ENERGY SOLUTIONS | 2026-Q2: No amount stated | 1 |
| CSL BEHRING | 2026-Q2: $60,000 in income | 1 |
| CURIE BIO OPERATIONS, LLC | 2026-Q2: $40,000 in income | 1 |
| DAIICHI SANKYO, INC. | 2026-Q2: $60,000 in income | 1 |
| ELI LILLY AND COMPANY | 2026-Q2: $60,000 in income | 1 |
| ENTERTAINMENT SOFTWARE ASSOCIATION | 2026-Q2: No amount stated | 1 |
| FEDERATION OF AMERICAN HOSPITALS | 2026-Q2: $60,000 in income | 1 |
| FGA ACTION, INC | 2026-Q2: $10,000 in income | 1 |
| FORD MOTOR COMPANY | 2026-Q2: No amount stated | 1 |
| GENENTECH, INC. | 2026-Q2: $60,000 in income | 1 |
| GLAXOSMITHKLINE | 2026-Q2: $50,000 in income | 1 |
| GOOGLE CLIENT SERVICES LLC | 2026-Q2: $60,000 in income | 1 |
| GRAIL, INC. | 2026-Q2: $60,000 in income | 1 |
| HOUSE RX, INC. | 2026-Q2: No amount stated | 1 |
| JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES | 2026-Q2: $40,000 in income | 1 |
| JP MORGAN CHASE HOLDINGS, LLC | 2026-Q2: $50,000 in income | 1 |
| PAC-12 CONFERENCE | 2026-Q2: No amount stated | 1 |
| PERSONAL CARE PRODUCTS COUNCIL | 2026-Q2: $30,000 in income | 1 |
| PFIZER, INC. | 2026-Q2: $60,000 in income | 1 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $40,000 in income | 1 |
| SANOFI U.S. SERVICES, INC. | 2026-Q2: $60,000 in income | 1 |
| SAPPHIRE DIGITAL | 2026-Q2: No amount stated | 1 |
| SOUTHEASTERN CONFERENCE | 2026-Q2: No amount stated | 1 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | 2026-Q2: $60,000 in income | 1 |
| THE BIG 12 CONFERENCE, INC. | 2026-Q2: No amount stated | 1 |
| THE BIG TEN CONFERENCE, INC. | 2026-Q2: No amount stated | 1 |
| VERIZON COMMUNICATIONS, INC. | 2026-Q2: No amount stated | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2026-Q2: $60,000 in income | 1 |
Lobbyists named in these reports
- HAZEN CLAY MARSHALL · 26 reports · earlier government job reported
- MONICA POPP · 25 reports · earlier government job reported
Bills named, and how the House and the Senate voted
16 bills named in these reports. 2 of them became law, and our record holds how the House and the Senate voted on them. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 7148Consolidated Appropriations Act, 2026 | Became law | Public Law 119-75House 217–214 · Senate 71–29 |
| H.R. 1227Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| H.R. 1476PLASMA Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 2300To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. | Introduced | No recorded vote in our record |
| H.R. 2911Accounting STEM Pursuit Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3512Tackling Predatory Litigation Funding Act | Introduced | No recorded vote in our record |
| H.R. 4776SPEED Act | Passed the House | No recorded vote in our record |
| H.R. 7613ALERT Act | Passed the House | No recorded vote in our record |
| S. 475Alternatives to PAIN Act | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 1705Chip Security Act | Introduced | No recorded vote in our record |
| S. 2175Pilot and Aircraft Privacy Act | Introduced | No recorded vote in our record |
| S. 2503ROTOR Act | Passed the Senate | No recorded vote in our record |
Issues named: Pharmacy (13), Trade (domestic/foreign) (10), Taxation/Internal Revenue Code (6), Copyright/Patent/Trademark (5), Medicare/Medicaid (5), Health Issues (3), Consumer Issues/Safety/Products (2), Advertising (1), Agriculture (1), Aviation/Airlines/Airports (1), Banking (1), Budget/Appropriations (1), and 5 mores.
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATEDMedicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| VERIZON COMMUNICATIONS, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| THE BIG TEN CONFERENCE, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| THE BIG 12 CONFERENCE, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| SOUTHEASTERN CONFERENCE | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| PAC-12 CONFERENCE | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| ATLANTIC COAST CONFERENCE | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| SUN PHARMACEUTICAL INDUSTRIES, INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| SAPPHIRE DIGITAL | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| SANOFI U.S. SERVICES, INC.Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| PFIZER, INC.Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| PERSONAL CARE PRODUCTS COUNCILConsumer Issues/Safety/Products, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| JP MORGAN CHASE HOLDINGS, LLCBanking | 2nd Quarter - Report | The report on LDA.gov | |
| JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCESHealth Issues, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| HOUSE RX, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| GRAIL, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GOOGLE CLIENT SERVICES LLCLabor Issues/Antitrust/Workplace, Consumer Issues/Safety/Products, Advertising, Science/Technology, Trade (domestic/foreign), Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| GLAXOSMITHKLINEPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| GENENTECH, INC.Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| FORD MOTOR COMPANY | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| FGA ACTION, INCBudget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| FEDERATION OF AMERICAN HOSPITALSMedicare/Medicaid, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| ENTERTAINMENT SOFTWARE ASSOCIATION | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| ELI LILLY AND COMPANYPharmacy, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| DAIICHI SANKYO, INC.Pharmacy, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| CURIE BIO OPERATIONS, LLCHealth Issues | 2nd Quarter - Termination | The report on LDA.gov | |
| CSL BEHRINGPharmacy, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| CITIZENS FOR RESPONSIBLE ENERGY SOLUTIONS | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| BUTTERFLY NETWORK, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| BRISTOL-MYERS SQUIBB COMPANYPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| BRIDGEBIO PHARMAPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| AMGEN USA INC.Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| ALTRIA CLIENT SERVICESTobacco | 2nd Quarter - Report | The report on LDA.gov | |
| AICPA ASSOCIATION OF INTERNATIONAL CERTIFIED PROFESSIONAL ACCOUNTANTSTaxation/Internal Revenue Code, Education | 2nd Quarter - Report | The report on LDA.gov | |
| AIRPORTS COUNCIL INTERNATIONAL - NORTH AMERICAAviation/Airlines/Airports | 2nd Quarter - Report | The report on LDA.gov | |
| A PLACE FOR MOM, INC. | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| ABBVIE INC.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| ABBOTT LABORATORIESAgriculture, Medicare/Medicaid, Taxation/Internal Revenue Code, Defense | 2nd Quarter - Report | The report on LDA.gov | |
| 3M COMPANY | 2nd Quarter - Report (No Activity) | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.